Veracyte Inc (VCYT) — Capital Reinvestment Ratio
Latest as of September 2025:
0.06x
Veracyte Inc (VCYT) has a Capital Reinvestment Ratio of 0.06x as of September 2025, meaning it reinvests 0% of its operating cash flow ($44.76 Million) in capital expenditures ($2.79 Million). See VCYT FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
$44.76 Million
USD
Capital Expenditures
$2.79 Million
USD
Data as of
Sep 2025
Most recent filing
Veracyte Inc Capital Reinvestment Ratio (2022–2024)
This chart tracks Veracyte Inc's Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Veracyte Inc (2022–2024)
Year-by-year Capital Reinvestment Ratio for Veracyte Inc from 2022 to 2024. For live market cap and broader valuation context, see VCYT stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.15x | $75.10 Million | $11.29 Million | ▼ -33.3% |
| 2023 | 0.23x | $44.22 Million | $9.96 Million | ▼ -80.1% |
| 2022 | 1.13x | $7.54 Million | $8.55 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow